Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Authors

• Jeremy Chataway, University College London
• Angelis F De
• Peter Connick, University of Edinburgh
• RA Parker
• Domenico Plantone, University College London
• Anisha Doshi, University College London
• Nevin John, University College London
• Jonathan Stutters, University College London
• David MacManus, University College London
• Carrasco F Prados
• Frederik Barkhof, University College London
• Sebastien Ourselin, King's College London
• Marie Braisher, University College London
• Moira Ross, University of Edinburgh
• Gina Cranswick, University of Edinburgh
• Sue H. Pavitt, University of Leeds
• Gavin Giovannoni, Queen Mary University of London
• Wheeler-Kingshott CA Gandini
• Clive Hawkins, Keele University
• Basil Sharrack, Royal Hallamshire Hospital
• Roger Bastow, Multiple Sclerosis Society
• Christopher J. Weir, University of Edinburgh
• Nigel Stallard, University of Warwick
• Siddharthan Chandran, University of Edinburgh
• Jeremy Chataway, University College London
• Wheeler-Kingshott CAM Gandini
• Angelis F De
• Domenico Plantone, University College London
• Anisha Doshi, University College London
• Dawn Lyle
• Thomas Williams
• Marie Braisher
• Tiggy Beyene
• Vanessa Bassan
• Alvin Zapata
• Siddharthan Chandran
• Peter Connick
• Dawn Lyle
• James Cameron
• Daisy Mollison
• Shuna Colville
• Baljean Dhillon
• Christopher J. Weir
• RA Parker
• Moira Ross
• Gina Cranswick
• Gavin Giovannoni
• Sharmilee Gnanapavan
• Richard Nicholas
• Waqar Rashid
• Julia Aram
• Helen Ford
• James Overell
• Carolyn Young
• Heinke Arndt
• Martin Duddy
• Joe Guadagno
• Nikolaos Evangelou
• Matthew Craner
• Jacqueline Palace
• Jeremy Hobart
• Basil Sharrack
• David Paling
• Clive Hawkins
• Seema Kalra
• B McLean
• Nigel Stallard
• Roger Bastow

DOI Link

10.1016/s1474-4422(19)30485-5

Publication Date

2020-01-01

Publication Title

The Lancet Neurology

Volume

19

Issue

3

ISSN

1474-4422

Acceptance Date

2019-12-05

Embargo Period

2020-07-28

First Page

214

Last Page

225

Recommended Citation

Chataway, J., De, A., Connick, P., Parker, R., Plantone, D., Doshi, A., John, N., Stutters, J., MacManus, D., Prados, C., Barkhof, F., Ourselin, S., Braisher, M., Ross, M., Cranswick, G., Pavitt, S., Giovannoni, G., Gandini, W., Hawkins, C., Sharrack, B., Bastow, R., Weir, C., Stallard, N., Chandran, S., Chataway, J., Gandini, W., De, A., Plantone, D., Doshi, A., Lyle, D., Williams, T., Braisher, M., Beyene, T., Bassan, V., Zapata, A., Chandran, S., Connick, P., Lyle, D., Cameron, J., Mollison, D., Colville, S., Dhillon, B., Weir, C., Parker, R., Ross, M., Cranswick, G., Giovannoni, G., Gnanapavan, S., Nicholas, R., Rashid, W., Aram, J., Ford, H., Overell, J., Young, C., Arndt, H., Duddy, M., Guadagno, J., Evangelou, N., Craner, M., Palace, J., Hobart, J., Sharrack, B., Paling, D., Hawkins, C., Kalra, S., McLean, B., Stallard, N., & Bastow, R. (2020) 'Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial', The Lancet Neurology, 19(3), pp. 214-225. Available at: 10.1016/s1474-4422(19)30485-5